bcr_patient_barcode	type	age_at_initial_pathologic_diagnosis	gender	race	clinical_stage	histological_type	histological_grade	menopause_status	tumor_status	new_tumor_event_type	treatment_outcome_first_course	OS	OS.time	DSS	DSS.time	DFI	DFI.time	PFI	PFI.time
TCGA-2E-A9G8	UCEC	59	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_III	Endometrioid_endometrial_adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	Locoregional_Recurrence	Progressive_Disease	0	1249	0	1249	NA	NA	1	335
TCGA-4E-A92E	UCEC	54	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_I	Endometrioid_endometrial_adenocarcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	13	0	13	0	13	0	13
TCGA-5B-A90C	UCEC	69	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	Locoregional_Recurrence	NA	0	1202	0	1202	NA	NA	1	517
TCGA-5S-A9Q8	UCEC	51	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIA	Endometrioid_endometrial_adenocarcinoma	G2	NA	NA	NA	Complete_Remission/Response	0	313	0	313	0	313	0	313
TCGA-A5-A1OH	UCEC	86	FEMALE	WHITE	Stage_IIIA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1105	0	1105	0	1105	0	1105
TCGA-A5-A2K2	UCEC	77	FEMALE	WHITE	Stage_IA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	3595	0	3595	0	3595	0	3595
TCGA-A5-A2K3	UCEC	68	FEMALE	WHITE	Stage_IA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	2012	0	2012	0	2012	0	2012
TCGA-A5-A2K4	UCEC	69	FEMALE	WHITE	Stage_IIIA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Metastatic	Complete_Remission/Response	1	871	1	871	1	528	1	528
TCGA-A5-A2K5	UCEC	76	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	752	0	752	0	752	0	752
TCGA-A5-A2K7	UCEC	41	FEMALE	NA	Stage_II	Endometrioid_endometrial_adenocarcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1063	0	1063	0	1063	0	1063
TCGA-A5-A3LO	UCEC	64	FEMALE	WHITE	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	776	0	776	0	776	0	776
TCGA-A5-A3LP	UCEC	74	FEMALE	WHITE	Stage_IB	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	455	0	455	0	455	0	455
TCGA-A5-A7WJ	UCEC	64	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	341	0	341	0	341	0	341
TCGA-A5-A7WK	UCEC	71	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Mixed_serous_and_endometrioid	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	0	560	0	560	1	350	1	350
TCGA-A5-AB3J	UCEC	52	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_II	Endometrioid_endometrial_adenocarcinoma	G2	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	512	0	512	0	512	0	512
TCGA-AJ-A23N	UCEC	70	FEMALE	WHITE	Stage_IIIA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	Progressive_Disease	1	439	1	439	NA	NA	1	439
TCGA-AJ-A2QM	UCEC	67	FEMALE	WHITE	Stage_II	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	894	0	894	0	894	0	894
TCGA-AJ-A2QO	UCEC	85	FEMALE	WHITE	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	1	1045	0	1045	0	1045	0	1045
TCGA-AJ-A3BD	UCEC	57	FEMALE	WHITE	Stage_IIIC2	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1039	0	1039	0	1039	0	1039
TCGA-AJ-A3BF	UCEC	65	FEMALE	WHITE	Stage_IIIC2	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	Locoregional_Recurrence	Complete_Remission/Response	0	551	0	551	1	384	1	384
TCGA-AJ-A3BG	UCEC	65	FEMALE	WHITE	Stage_IA	Mixed_serous_and_endometrioid	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	0	550	0	550	1	480	1	480
TCGA-AJ-A3BH	UCEC	NA	FEMALE	WHITE	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	0	NA	0	NA	NA	NA	0	NA
TCGA-AJ-A3BI	UCEC	67	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	Locoregional_Recurrence	NA	0	575	0	575	NA	NA	1	373
TCGA-AJ-A3BK	UCEC	68	FEMALE	WHITE	Stage_IC	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1031	0	1031	0	1031	0	1031
TCGA-AJ-A3EJ	UCEC	74	FEMALE	WHITE	Stage_IIIC2	Mixed_serous_and_endometrioid	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	NA	1	50	1	50	NA	NA	1	50
TCGA-AJ-A3EK	UCEC	53	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	446	0	446	0	446	0	446
TCGA-AJ-A3EL	UCEC	47	FEMALE	NATIVE_HAWAIIAN_OR_OTHER_PACIFIC_ISLANDER	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	684	0	684	0	684	0	684
TCGA-AJ-A3EM	UCEC	69	FEMALE	WHITE	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	677	0	677	0	677	0	677
TCGA-AJ-A3I9	UCEC	52	FEMALE	WHITE	Stage_II	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	519	1	519	1	370	1	370
TCGA-AJ-A3IA	UCEC	77	FEMALE	WHITE	Stage_IB	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	633	0	633	0	633	0	633
TCGA-AJ-A3NC	UCEC	63	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1125	0	1125	0	1125	0	1125
TCGA-AJ-A3NE	UCEC	46	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	628	0	628	0	628	0	628
TCGA-AJ-A3NF	UCEC	60	FEMALE	WHITE	Stage_IIIC	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	645	0	645	0	645	0	645
TCGA-AJ-A3NG	UCEC	83	FEMALE	WHITE	Stage_II	Mixed_serous_and_endometrioid	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	475	0	475	0	475	0	475
TCGA-AJ-A3NH	UCEC	90	FEMALE	WHITE	Stage_IB	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	1	310	0	310	0	310	0	310
TCGA-AJ-A3OJ	UCEC	54	FEMALE	WHITE	Stage_II	Endometrioid_endometrial_adenocarcinoma	G3	Indeterminate_(neither_Pre_or_Postmenopausal)	TUMOR_FREE	NA	Complete_Remission/Response	0	467	0	467	0	467	0	467
TCGA-AJ-A3OK	UCEC	73	FEMALE	WHITE	Stage_IA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	485	0	485	0	485	0	485
TCGA-AJ-A3OL	UCEC	55	FEMALE	WHITE	Stage_IIIA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	449	1	449	1	424	1	424
TCGA-AJ-A3QS	UCEC	57	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	513	0	513	0	513	0	513
TCGA-AJ-A3TW	UCEC	78	FEMALE	WHITE	Stage_IB	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	513	0	513	0	513	0	513
TCGA-AJ-A5DV	UCEC	65	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	679	0	679	0	679	0	679
TCGA-AJ-A5DW	UCEC	56	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	390	0	390	0	390	0	390
TCGA-AJ-A6NU	UCEC	64	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_II	Endometrioid_endometrial_adenocarcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	632	0	632	0	632	0	632
TCGA-AJ-A8CT	UCEC	58	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	82	0	82	0	82	0	82
TCGA-AJ-A8CV	UCEC	58	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1068	0	1068	0	1068	0	1068
TCGA-AJ-A8CW	UCEC	64	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	0	4	0	4	NA	NA	0	4
TCGA-AP-A3K1	UCEC	56	FEMALE	WHITE	Stage_IVB	Serous_endometrial_adenocarcinoma	High_Grade	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Progressive_Disease	1	666	1	666	NA	NA	1	198
TCGA-AP-A5FX	UCEC	68	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIC1	Mixed_serous_and_endometrioid	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	1	1099	1	1099	1	407	1	407
TCGA-AX-A05W	UCEC	60	FEMALE	WHITE	Stage_IIB	Endometrioid_endometrial_adenocarcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	2450	0	2450	0	2450	0	2450
TCGA-AX-A1C7	UCEC	77	FEMALE	WHITE	Stage_IB	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	NA	0	1054	0	1054	NA	NA	1	390
TCGA-AX-A2H4	UCEC	66	FEMALE	WHITE	Stage_IIIA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Disease	Complete_Remission/Response	1	916	1	916	1	520	1	520
TCGA-AX-A2HH	UCEC	60	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	NA	WITH_TUMOR	NA	Partial_Remission/Response	0	540	0	540	NA	NA	0	540
TCGA-AX-A2IN	UCEC	63	FEMALE	WHITE	Stage_IC	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	New_Primary_Tumor	NA	1	947	1	947	NA	NA	1	257
TCGA-AX-A3FS	UCEC	82	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	NA	0	7	0	7	NA	NA	0	7
TCGA-AX-A3FT	UCEC	64	FEMALE	WHITE	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	NA	0	6	0	6	NA	NA	0	6
TCGA-AX-A3FV	UCEC	62	FEMALE	WHITE	Stage_IIIA	Endometrioid_endometrial_adenocarcinoma	G3	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0
TCGA-AX-A3FW	UCEC	66	FEMALE	WHITE	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	NA	0	17	0	17	NA	NA	0	17
TCGA-AX-A3FX	UCEC	69	FEMALE	WHITE	Stage_IIB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	Locoregional_Recurrence	NA	1	1333	NA	1333	NA	NA	1	938
TCGA-AX-A3FZ	UCEC	33	FEMALE	WHITE	Stage_IIIB	Endometrioid_endometrial_adenocarcinoma	G3	NA	NA	NA	NA	0	6	0	6	NA	NA	0	6
TCGA-AX-A3G1	UCEC	84	FEMALE	WHITE	Stage_IC	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	NA	1	624	NA	624	NA	NA	0	624
TCGA-AX-A3G4	UCEC	60	FEMALE	NATIVE_HAWAIIAN_OR_OTHER_PACIFIC_ISLANDER	Stage_IIIC	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	NA	0	9	0	9	NA	NA	0	9
TCGA-AX-A3G6	UCEC	67	FEMALE	WHITE	Stage_IA	Serous_endometrial_adenocarcinoma	G2	NA	NA	NA	NA	0	8	0	8	NA	NA	0	8
TCGA-AX-A3G7	UCEC	71	FEMALE	WHITE	Stage_IVB	Serous_endometrial_adenocarcinoma	G3	NA	NA	NA	NA	0	9	0	9	NA	NA	0	9
TCGA-AX-A3G8	UCEC	76	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	NA	0	36	0	36	NA	NA	0	36
TCGA-AX-A3G9	UCEC	63	FEMALE	WHITE	Stage_IIIC	Endometrioid_endometrial_adenocarcinoma	G3	NA	NA	NA	NA	0	558	0	558	NA	NA	0	558
TCGA-AX-A3GB	UCEC	73	FEMALE	WHITE	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	NA	0	440	0	440	NA	NA	0	440
TCGA-AX-A3GI	UCEC	66	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIC	Serous_endometrial_adenocarcinoma	G3	NA	NA	NA	NA	0	12	0	12	NA	NA	0	12
TCGA-B5-A0JN	UCEC	84	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IVB	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	2445	0	2445	NA	NA	0	2445
TCGA-B5-A0JR	UCEC	73	FEMALE	WHITE	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1731	0	1731	0	1731	0	1731
TCGA-B5-A0K9	UCEC	88	FEMALE	WHITE	Stage_II	Endometrioid_endometrial_adenocarcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	1	409	0	409	0	409	0	409
TCGA-B5-A11R	UCEC	51	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_II	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	2349	0	2349	0	2349	0	2349
TCGA-B5-A1MS	UCEC	60	FEMALE	WHITE	Stage_IC	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Partial_Remission/Response	1	3112	1	3112	NA	NA	1	2706
TCGA-B5-A1MW	UCEC	55	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	Locoregional_Disease	Complete_Remission/Response	0	447	0	447	1	311	1	311
TCGA-B5-A3F9	UCEC	56	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	0	4155	0	4155	NA	NA	0	4155
TCGA-B5-A3FA	UCEC	73	FEMALE	WHITE	Stage_IC	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	0	2929	0	2929	NA	NA	0	2929
TCGA-B5-A3FB	UCEC	73	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	0	2844	0	2844	NA	NA	0	2844
TCGA-B5-A3FC	UCEC	53	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_II	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	0	2185	0	2185	NA	NA	0	2185
TCGA-B5-A3FD	UCEC	70	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Indeterminate_(neither_Pre_or_Postmenopausal)	TUMOR_FREE	Locoregional_Recurrence	NA	1	1197	0	1197	NA	NA	1	562
TCGA-B5-A3FH	UCEC	74	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	841	0	841	0	841	0	841
TCGA-B5-A3S1	UCEC	71	FEMALE	WHITE	Stage_IIIC1	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	Complete_Remission/Response	0	902	0	902	0	902	0	902
TCGA-B5-A5OC	UCEC	71	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIB	Endometrioid_endometrial_adenocarcinoma	G3	NA	TUMOR_FREE	NA	NA	0	1249	0	1249	NA	NA	0	1249
TCGA-B5-A5OD	UCEC	67	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIC	Serous_endometrial_adenocarcinoma	G3	NA	TUMOR_FREE	NA	NA	0	1038	0	1038	NA	NA	0	1038
TCGA-B5-A5OE	UCEC	68	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIC2	Serous_endometrial_adenocarcinoma	G3	NA	TUMOR_FREE	NA	NA	0	1063	0	1063	NA	NA	0	1063
TCGA-BG-A0MK	UCEC	52	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIB	Endometrioid_endometrial_adenocarcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	NA	Progressive_Disease	1	1317	1	1317	NA	NA	1	1317
TCGA-BG-A3EW	UCEC	62	FEMALE	WHITE	Stage_III	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	344	0	344	0	344	0	344
TCGA-BG-A3PP	UCEC	82	FEMALE	WHITE	Stage_II	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Progressive_Disease	0	681	0	681	NA	NA	1	665
TCGA-BK-A13B	UCEC	58	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	0	966	0	966	1	760	1	760
TCGA-BK-A4ZD	UCEC	42	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	506	0	506	0	506	0	506
TCGA-BK-A56F	UCEC	75	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	401	0	401	0	401	0	401
TCGA-BK-A6W3	UCEC	34	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_II	Endometrioid_endometrial_adenocarcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	305	0	305	0	305	0	305
TCGA-BK-A6W4	UCEC	62	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	300	0	300	0	300	0	300
TCGA-BS-A0V4	UCEC	56	FEMALE	WHITE	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1810	0	1810	0	1810	0	1810
TCGA-BS-A0V7	UCEC	48	FEMALE	NATIVE_HAWAIIAN_OR_OTHER_PACIFIC_ISLANDER	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G1	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1934	0	1934	0	1934	0	1934
TCGA-D1-A2G0	UCEC	70	FEMALE	WHITE	Stage_IB	Mixed_serous_and_endometrioid	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	0	1484	0	1484	NA	NA	0	1484
TCGA-D1-A3DA	UCEC	77	FEMALE	WHITE	Stage_IIIC1	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	483	0	483	0	483	0	483
TCGA-D1-A3DG	UCEC	81	FEMALE	WHITE	Stage_IVB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	1	130	0	130	NA	NA	0	130
TCGA-D1-A3DH	UCEC	71	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	573	0	573	0	573	0	573
TCGA-D1-A3JQ	UCEC	61	FEMALE	WHITE	Stage_IIIC	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	526	0	526	0	526	0	526
TCGA-DF-A2KN	UCEC	NA	FEMALE	NA	Stage_IC	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	67	0	67	0	67	0	67
TCGA-DF-A2KR	UCEC	84	FEMALE	NA	Stage_IIIC	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	New_Primary_Tumor	Complete_Remission/Response	0	2178	0	2178	0	2178	1	2113
TCGA-DF-A2KU	UCEC	NA	FEMALE	NA	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	3067	0	3067	0	3067	0	3067
TCGA-DF-A2KV	UCEC	55	FEMALE	NA	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	0	2717	0	2717	NA	NA	0	2717
TCGA-DF-A2KY	UCEC	49	FEMALE	NA	Stage_IVA	Endometrioid_endometrial_adenocarcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	NA	NA	0	332	0	332	NA	NA	0	332
TCGA-DF-A2KZ	UCEC	87	FEMALE	NA	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	0	826	0	826	NA	NA	0	826
TCGA-DF-A2L0	UCEC	60	FEMALE	NA	Stage_IIIC	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	788	1	788	1	523	1	523
TCGA-DI-A1BU	UCEC	55	FEMALE	WHITE	Stage_IIB	Mixed_serous_and_endometrioid	G3	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	1195	0	1195	0	1195	0	1195
TCGA-DI-A1C3	UCEC	38	FEMALE	WHITE	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G2	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	739	0	739	0	739	0	739
TCGA-DI-A2QT	UCEC	51	FEMALE	AMERICAN_INDIAN_OR_ALASKA_NATIVE	Stage_IIIC	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	NA	1	377	1	377	NA	NA	1	377
TCGA-DI-A2QY	UCEC	64	FEMALE	WHITE	Stage_IIB	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	1	3349	0	3349	0	3349	0	3349
TCGA-E6-A2P8	UCEC	53	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IV	Mixed_serous_and_endometrioid	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Metastatic	Progressive_Disease	1	72	1	72	NA	NA	1	60
TCGA-E6-A2P9	UCEC	65	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1386	0	1386	0	1386	0	1386
TCGA-E6-A8L9	UCEC	61	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1013	0	1013	0	1013	0	1013
TCGA-EO-A1Y7	UCEC	65	FEMALE	NA	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Progressive_Disease	0	1495	0	1495	NA	NA	1	880
TCGA-EO-A22U	UCEC	83	FEMALE	WHITE	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1407	0	1407	0	1407	0	1407
TCGA-EO-A22X	UCEC	36	FEMALE	NA	Stage_IIIA	Endometrioid_endometrial_adenocarcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1752	0	1752	0	1752	0	1752
TCGA-EO-A22Y	UCEC	68	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1567	0	1567	0	1567	0	1567
TCGA-EO-A3AS	UCEC	86	FEMALE	NA	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1046	0	1046	0	1046	0	1046
TCGA-EO-A3AU	UCEC	72	FEMALE	NA	Stage_II	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	New_Primary_Tumor	Complete_Remission/Response	0	1543	0	1543	0	1543	1	1178
TCGA-EO-A3AV	UCEC	51	FEMALE	NA	Stage_IIIC1	Endometrioid_endometrial_adenocarcinoma	G3	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	1069	0	1069	0	1069	0	1069
TCGA-EO-A3AY	UCEC	58	FEMALE	NA	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	0	1158	0	1158	1	1163	1	1163
TCGA-EO-A3AZ	UCEC	80	FEMALE	NA	Stage_IB	Mixed_serous_and_endometrioid	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	826	0	826	0	826	0	826
TCGA-EO-A3B0	UCEC	43	FEMALE	ASIAN	Stage_IIIC2	Endometrioid_endometrial_adenocarcinoma	G3	Indeterminate_(neither_Pre_or_Postmenopausal)	TUMOR_FREE	NA	NA	0	1412	0	1412	NA	NA	0	1412
TCGA-EO-A3B1	UCEC	63	FEMALE	NA	Stage_IB	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	820	0	820	0	820	0	820
TCGA-EO-A3KU	UCEC	68	FEMALE	NA	Stage_II	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	677	0	677	0	677	0	677
TCGA-EO-A3KW	UCEC	72	FEMALE	NA	Stage_IA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	497	0	497	0	497	0	497
TCGA-EO-A3KX	UCEC	80	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1170	0	1170	0	1170	0	1170
TCGA-EO-A3L0	UCEC	76	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1554	0	1554	0	1554	0	1554
TCGA-EY-A1GL	UCEC	51	FEMALE	WHITE	Stage_II	Endometrioid_endometrial_adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1014	0	1014	0	1014	0	1014
TCGA-EY-A1GO	UCEC	65	FEMALE	WHITE	Stage_IIIC1	Endometrioid_endometrial_adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Metastatic	Complete_Remission/Response	0	586	0	586	1	517	1	517
TCGA-EY-A1GP	UCEC	54	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	573	0	573	0	573	0	573
TCGA-EY-A1GX	UCEC	76	FEMALE	WHITE	Stage_IIIA	Endometrioid_endometrial_adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	Locoregional_Recurrence	Complete_Remission/Response	1	1127	0	1127	1	743	1	743
TCGA-EY-A210	UCEC	82	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIC2	Mixed_serous_and_endometrioid	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	383	0	383	0	383	0	383
TCGA-EY-A2ON	UCEC	61	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IVB	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	Progressive_Disease	1	610	1	610	NA	NA	1	226
TCGA-EY-A2OO	UCEC	56	FEMALE	WHITE	Stage_IB	Mixed_serous_and_endometrioid	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1392	0	1392	0	1392	0	1392
TCGA-EY-A2OP	UCEC	63	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	944	0	944	0	944	0	944
TCGA-EY-A2OQ	UCEC	61	FEMALE	WHITE	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	885	0	885	0	885	0	885
TCGA-EY-A3L3	UCEC	82	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	832	0	832	0	832	0	832
TCGA-EY-A3QX	UCEC	64	FEMALE	WHITE	Stage_IVB	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	1	989	1	989	NA	NA	1	896
TCGA-EY-A4KR	UCEC	56	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIC1	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	Progressive_Disease	1	346	1	346	NA	NA	1	346
TCGA-EY-A547	UCEC	75	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	545	0	545	0	545	0	545
TCGA-EY-A548	UCEC	83	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	430	0	430	0	430	0	430
TCGA-EY-A549	UCEC	78	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	605	0	605	0	605	0	605
TCGA-EY-A54A	UCEC	67	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIC2	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	447	0	447	0	447	0	447
TCGA-EY-A5W2	UCEC	72	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	516	0	516	0	516	0	516
TCGA-EY-A72D	UCEC	87	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_II	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	179	0	179	0	179	0	179
TCGA-FI-A2EY	UCEC	63	FEMALE	WHITE	Stage_IIIA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	New_Primary_Tumor	Complete_Remission/Response	1	880	0	880	0	880	1	577
TCGA-FI-A3PV	UCEC	68	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Serous_endometrial_adenocarcinoma	High_Grade	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	NA	1	1249	1	1249	NA	NA	1	1249
TCGA-FI-A3PX	UCEC	57	FEMALE	WHITE	Stage_IIIC2	Serous_endometrial_adenocarcinoma	High_Grade	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	2384	0	2384	0	2384	0	2384
TCGA-H5-A2HR	UCEC	71	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	0	53	0	53	NA	NA	0	53
TCGA-JU-AAVI	UCEC	61	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIC1	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	540	1	540	1	505	1	505
TCGA-K6-A3WQ	UCEC	60	FEMALE	WHITE	Stage_IVB	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	NA	1	427	1	427	NA	NA	1	351
TCGA-KP-A3VZ	UCEC	69	FEMALE	WHITE	Stage_IV	Serous_endometrial_adenocarcinoma	High_Grade	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	NA	0	722	0	722	NA	NA	0	722
TCGA-KP-A3W0	UCEC	72	FEMALE	NA	Stage_IB	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	404	0	404	0	404	0	404
TCGA-KP-A3W1	UCEC	76	FEMALE	NA	Stage_IA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	288	0	288	0	288	0	288
TCGA-KP-A3W3	UCEC	72	FEMALE	WHITE	Stage_IB	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	0	794	0	794	1	661	1	661
TCGA-KP-A3W4	UCEC	63	FEMALE	WHITE	Stage_IIIA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Partial_Remission/Response	1	554	1	554	NA	NA	1	321
TCGA-PG-A5BC	UCEC	72	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_II	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	707	0	707	0	707	0	707
TCGA-PG-A6IB	UCEC	68	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	648	0	648	0	648	0	648
TCGA-PG-A7D5	UCEC	62	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Stable_Disease	0	1177	0	1177	NA	NA	0	1177
TCGA-PG-A914	UCEC	73	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	687	0	687	0	687	0	687
TCGA-PG-A915	UCEC	60	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	249	0	249	0	249	0	249
TCGA-PG-A916	UCEC	70	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_I	Endometrioid_endometrial_adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	522	0	522	0	522	0	522
TCGA-PG-A917	UCEC	74	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA	Endometrioid_endometrial_adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	212	0	212	0	212	0	212
TCGA-QF-A5YS	UCEC	57	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_II	Mixed_serous_and_endometrioid	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	689	0	689	0	689	0	689
TCGA-QF-A5YT	UCEC	57	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_II	Endometrioid_endometrial_adenocarcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1215	0	1215	0	1215	0	1215
TCGA-QS-A5YQ	UCEC	55	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIA	Endometrioid_endometrial_adenocarcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	759	0	759	0	759	0	759
TCGA-QS-A5YR	UCEC	61	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIB	Endometrioid_endometrial_adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	Stable_Disease	0	719	0	719	NA	NA	0	719
TCGA-QS-A744	UCEC	86	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIB	Endometrioid_endometrial_adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	0	451	0	451	NA	NA	0	451
TCGA-QS-A8F1	UCEC	85	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIA	Serous_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	Progressive_Disease	1	135	1	135	NA	NA	1	135
TCGA-SJ-A6ZI	UCEC	64	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G1	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	631	0	631	0	631	0	631
TCGA-SJ-A6ZJ	UCEC	61	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	556	0	556	0	556	0	556
TCGA-SL-A6J9	UCEC	73	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	NA	0	2	0	2	NA	NA	0	2
TCGA-SL-A6JA	UCEC	77	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Endometrioid_endometrial_adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	7	0	7	0	7	0	7
